Skip to main content
SpringerLink
Log in

PET (Positronenemissionstomografie) in der Gliomchirurgie

  • Chapter
  • First Online:
Gliomchirurgie

  • 1453 Accesses

Zusammenfassung

Die Positronenemissionstomografie (PET) ist ein nuklearmedizinisches Schnittbildverfahren. Ergänzend zur MRT können Stoffwechselprozesse dargestellt werden, die Rückschlüsse auf Tumorhistologie oder Therapieverläufe zulassen. Im Folgenden werden die klinisch relevanten Aspekte der PET aus Sicht der operativen Neuroonkologie dargestellt.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 229.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  • Chen W (2007) Clinical applications of PET in brain tumors. J Nucl Med 48 (9): 1468–81.

    Article  PubMed  Google Scholar 

  • Chung JK, YK Kim, SK Kim, YJ Lee, S Paek, JS Yeo, JM Jeong, DS Lee, HW Jung, MC Lee (2002) Usefulness of 11C-methionine PET in the evaluation of brain lesions that are hypo- or isometabolic on 18F-FDG PET. Eur J Nucl Med Mol Imaging 29 (2): 176–82.

    Article  CAS  PubMed  Google Scholar 

  • Dunet V, A Pomoni, A Hottinger, M Nicod-Lalonde, JO Prior (2016) Performance of 18F-FET versus 18F-FDG-PET for the diagnosis and grading of brain tumors: systematic review and meta-analysis. Neuro Oncol 18(3): 426–34.

    Article  PubMed  Google Scholar 

  • Dunkl V, C Cleff, G Stoffels, N Judov, S Sarikaya-Seiwert, I Law, L Bogeskov, K Nysom, SB Andersen, HJ Steiger, GR Fink, G Reifenberger, NJ Shah, HH Coenen, KJ Langen, N Galldiks (2015) The usefulness of dynamic O-(2-18F-fluoroethyl)-L-tyrosine PET in the clinical evaluation of brain tumors in children and adolescents. J Nucl Med 56 (1): 88–92.

    Article  CAS  PubMed  Google Scholar 

  • Galldiks N, V Dunkl, G Stoffels, M Hutterer, M Rapp, M Sabel, G Reifenberger, S Kebir, F Dorn, T Blau, U Herrlinger, P Hau, MI Ruge, M Kocher, R Goldbrunner, GR Fink, A Drzezga, M Schmidt, KJ Langen (2015) Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[18F]fluoroethyl)-L-tyrosine PET. Eur J Nucl Med Mol Imaging 42 (5): 685–95.

    Article  CAS  PubMed  Google Scholar 

  • Galldiks N, G Stoffels, C Filss, M Rapp, T Blau, C Tscherpel, G Ceccon, V Dunkl, M Weinzierl, M Stoffel, M Sabel, GR Fink, NJ Shah, KJ Langen (2015) The use of dynamic O-(2-18F-fluoroethyl)-l-tyrosine PET in the diagnosis of patients with progressive and recurrent glioma. Neuro Oncol 17 (9): 1293–300.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Herholz K, T Holzer, B Bauer, R Schroder, J Voges, RI Ernestus, G Mendoza, G Weber-Luxenburger, J Lottgen, A Thiel, K Wienhard, WD Heiss (1998) 11C-methionine PET for differential diagnosis of low-grade gliomas. Neurology 50 (5): 1316–22.

    Article  CAS  PubMed  Google Scholar 

  • Hutterer M, E Hattingen, C Palm, MA Proescholdt, P Hau (2015) Current standards and new concepts in MRI and PET response assessment of antiangiogenic therapies in high-grade glioma patients. Neuro Oncol 17 (6): 784–800.

    Article  CAS  PubMed  Google Scholar 

  • Jansen NL, B Suchorska, V Wenter, C Schmid-Tannwald, A Todica, S Eigenbrod, M Niyazi, JC Tonn, P Bartenstein, FW Kreth, C la Fougere (2015) Prognostic significance of dynamic 18F-FET PET in newly diagnosed astrocytic high-grade glioma. J Nucl Med 56 (1): 9–15.

    Article  CAS  PubMed  Google Scholar 

  • Kaschten B, A Stevenaert, B Sadzot, M Deprez, C Degueldre, G Del Fiore, A Luxen, M Reznik (1998) Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine. J Nucl Med 39 (5): 778–85.

    CAS  PubMed  Google Scholar 

  • Munck Af, Rosenschold P, J Costa, SA Engelholm, MJ Lundemann, I Law, L Ohlhues, S Engelholm (2015) Impact of [18F]-fluoro-ethyl-tyrosine PET imaging on target definition for radiation therapy of high-grade glioma. Neuro Oncol 17 (5): 757–63.

    Article  Google Scholar 

  • Pauleit D, F Floeth, K Hamacher, MJ Riemenschneider, G Reifenberger, HW Muller, K Zilles, HH Coenen, KJ Langen (2005) O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas. Brain 128(Pt3): 678–87.

    Article  PubMed  Google Scholar 

  • Pichler R, A Dunzinger, G Wurm, J Pichler, S Weis, K Nussbaumer, Topakian R, Aigner RM (2010) Is there a place for FET PET in the initial evaluation of brain lesions with unknown significance? Eur J Nucl Med Mol Imaging 37 (8): 1521–8.

    Article  PubMed  Google Scholar 

  • Plotkin M, Blechschmidt C, Auf G, Nyuyki F, Geworski L, Denecke T, Brenner W, Stockhammer F (2010) Comparison of F-18 FET-PET with F-18 FDG-PET for biopsy planning of non-contrast-enhancing gliomas. Eur Radiol 20 (10): 2496–502.

    Article  PubMed  Google Scholar 

  • Plotkin M, Gneveckow U, Meier-Hauff K, Amthauer H, Feussner A, Denecke T, Gutberlet M, Jordan A, Felix R, Wust P (2006) 18F-FET PET for planning of thermotherapy using magnetic nanoparticles in recurrent glioblastoma. Int J Hyperthermia 22 (4): 319–25.

    Article  CAS  PubMed  Google Scholar 

  • Plotkin M, Guggemos A, Grosse F, Steffen I-G, Hernáiz-Driever P (2014) Rolle der PET in der Diagnostik von Hirntumoren im Kindes- und Jugendalter. Nuklearmediziner 37 (4):4.

    Google Scholar 

  • Popperl G, Gotz C, Rachinger W, Gildehaus FJ, Tonn JC, Tatsch K (2004) Value of O-(2-[18F]fluoroethyl)- L-tyrosine PET for the diagnosis of recurrent glioma. Eur J Nucl Med Mol Imaging 31 (11): 1464–70.

    Article  PubMed  Google Scholar 

  • Stockhammer F, Misch M, Horn P, Koch A, Fonyuy N, Plotkin M (2009) Association of F18-fluoro-ethyl-tyrosin uptake and 5-aminolevulinic acid-induced fluorescence in gliomas. Acta Neurochir (Wien) 151 (11): 1377–83.

    Article  Google Scholar 

  • Suchorska B, Jansen NL, Linn J, Kretzschmar H, Janssen H, Eigenbrod S, Simon M, Popperl G, Kreth FW, Fougere C la, Weller M, Tonn JC, Network German Glioma (2015) Biological tumor volume in 18FET-PET before radiochemotherapy correlates with survival in GBM. Neurology 84 (7): 710–9.

    Article  CAS  PubMed  Google Scholar 

  • Terakawa Y, Tsuyuguchi N, Iwai Y, Yamanaka K, Higashiyama S, Takami T, Ohata K (2008) Diagnostic accuracy of 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy. J Nucl Med 49 (5): 694–9.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Neurochirurgie, Städt. Klinikum D.-Friedrichstadt, Friedrichstr. 41, 01067, Dresden, Deutschland

    Florian Stockhammer

Authors
  1. Florian Stockhammer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Florian Stockhammer .

Editor information

Editors and Affiliations

  1. Klinik für Neurochirurgie, Ev. Klinikum Bethel, Bielefeld, Germany

    Matthias Simon

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Stockhammer, F. (2018). PET (Positronenemissionstomografie) in der Gliomchirurgie. In: Simon, M. (eds) Gliomchirurgie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-48694-8_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-48694-8_3

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-48693-1

  • Online ISBN: 978-3-662-48694-8

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation